Related by context. Frequent words. (Click for all words.) 66 RXi Pharmaceutical Corporation 56 concerning Alnylam 56 inflammatory autoimmune diseases 55 immunotherapeutics 55 differentiated therapeutics 54 Embryome Sciences 54 novel RNAi therapeutics 54 functional genomics proteomics 54 Diatos 54 forward lookingstatements 53 regarding Heska 53 Hybridon 52 OctoPlus NV 52 ProMetic objectives 52 www.vivus.com 52 Genaissance 51 Resverlogix Corp. 51 CMV vaccine 51 TranSwitch indebtedness 51 GVAX cancer 51 strategy summarization 51 intents beliefs 51 Sangamo ZFP technology 51 Eligard R 51 theranostic 50 Prelude SkinPrep Systems 50 involves Activision Publishing 50 Nanobac Pharmaceuticals Inc. 50 TOCOSOL Paclitaxel 50 expectations anticipations estimates 50 outlicense 50 iCo Therapeutics 50 please visit http:/www.supergen.com 50 strategy GlobalData summarization 49 Statements Certain 49 * Potentially libelous 49 suchforward looking 49 outlicensing 49 aesthetic medicine BioLook 49 Apthera 49 Addex Pharmaceuticals Ltd 49 Cobalamin 49 Neuro Hitech 49 Agios Pharmaceuticals 49 Nautilus Biotech 49 molecular chaperone 49 SensiGen 49 visit www.3M.com 49 siRNA therapeutics 48 Kensington Leasing 48 should consult Cytokinetics 48 Furthermore Cephalon 48 website www.octoplus.nl 48 optical biosensors 48 acquisitions mergers dispositions 48 Dyax utilizes 48 Vaccinex 48 Gemin X 48 successfully commercialize 48 theforward looking 48 concerning Basilea Pharmaceutica 48 produces Chrysler Jeep 48 HepeX B 48 www.spectrumpharm.com 48 Mannatech objectives 48 Galenea 48 objectives expectations anticipations 48 risks anduncertainties 48 IntegraGen 48 Hiru Corporation 47 therapeutic monoclonal antibodies 47 Euroscreen 47 commercialize 47 development diagnostics combinatorial 47 Exploit collaboration 47 Ibis T# 47 Scancell 47 Neo Urinary Conduit 47 Verenium dependence 47 generation calcineurin inhibitor 47 commercialize telaprevir 47 ATK undertakes 47 prodrugs 47 epothilone 47 strategy Analyst summarization 47 Perlegen Sciences 47 DWS Trust 47 codevelop 47 within themeaning 47 acquisitions divestitures mergers 47 OSI Prosidion 47 TapImmune 47 cancer immunotherapies 47 www.tekmirapharm.com 46 Rosetta dependence 46 products andservices 46 Technest Holdings 46 Antigen Express website 46 Epitomics 46 ophthalmic diseases 46 ACS disclaims